Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
PI3K/Akt/mTOR Pathway
PI3K/Akt/mTOR Pathway
/
Akt
Akt
Akt
Products (24)
Ipatasertib
CAS No.:
1001264-89-6
Recilisib Sodium
CAS No.:
922139-31-9
Capivasertib
CAS No.:
1143532-39-1
1-[2-[7-[2,4-difluoro-6-(2-methoxyethoxy)phenyl]-4-(1-methylindazol-5-yl)thieno[3,2-c]pyridin-6-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl]prop-2-en-1-one
CAS No.:
2971769-60-3
2-(3-(1-(((4E,10E)-2,9-Dioxo-12-isopropyl-1,8-diazacyclododecane-4,10-diene-3-yl)carbamoyl)-2-methylpropyl)ureido)-3-methylbutyric acid
CAS No.:
212115-96-3
Vevorisertib trihydrochloride
CAS No.:
1416775-08-0
N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)thiophene-2-carboxamide
CAS No.:
1047634-63-8
Uprosertib
CAS No.:
1047634-65-0
TIC10 isomer
CAS No.:
41276-02-2
2-Chlorophenoxazine
CAS No.:
56821-03-5
Miransertib
CAS No.:
1313881-70-7
Creatine Monohydrate
CAS No.:
6020-87-7
Bay-1125976
CAS No.:
1402608-02-9
Mk-2206
CAS No.:
1032349-77-1
Oridonin
CAS No.:
28957-04-2
Perifosine
CAS No.:
157716-52-4
Cmx-2043
CAS No.:
910627-26-8
PF-Akt400
CAS No.:
1004990-28-6
Zandelisib
CAS No.:
1401436-95-0
Engasertib
CAS No.:
1313439-71-2
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact